Brain Biotech AG/ DE0005203947 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 59.13 mill.USD | - | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.25 EUR | -51.92% |
EPS Diluted: | -0.25 EUR | -51.92% |
Revenues per Share: | 2.04 EUR | -2.86% |
Book Value per Share: | 1.95 EUR | 74.52% |
Cash Flow per Share: | -0.20 EUR | -23.99% |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 40.70 EUR | 3.83% |
Net Income: | -5.00 EUR | -48.45% |
Operating Cash Flow: | -3.90 EUR | - |
Cash and Cash Equivalents: | 24.50 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 1.36 | 4.86 |
P/BV ratio: | 1.43 | 5.10 |
P/CF Ratio: | -14.22 | -50.73 |
PEG: | 0.21 | - |
Earnings Yield: | -8.99% | -2.52% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 59.13 mill. USD | 224.07 mill. USD |
Free Float Market Cap.: | 27.97 mill. USD | 105.98 mill. USD |
Market Cap. / Employee: | 205,326.2033 USD | 778,011.8843 USD |
Shares Outstanding: | 21.85 mill. |
Profitability
Gross Profit Margin: | 58.72% |
EBIT Margin: | -15.97% |
Net Profit Margin: | -12.29% |
Return on Equity: | -12.89% |
Return on Assets: | -6.44% |
Financial Strength
Liquidity I / Cash Ratio: | 216.81% |
Liquidity II / Quick Ratio: | 216.81% |
Liquidity III / Current Ratio: | 346.02% |
Debt / Equity Ratio: | 100.26% |
Dynam. Debt / Equity Ratio: | -997.44% |
Efficiency
Employees: | 288 |
Personal Expenses / Employee: | 67,708.33 EUR |
Revenues / Employee: | 141,319.44 EUR |
Net Income / Employee: | -17,361.11 EUR |
Total Assets / Employee: | 269,791.67 EUR |
* Fiscal Year End: | 2021-09-30 |
Accounting Standard: | IFRS |
Currency: | EUR |